Stay updated on Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.6.6 to v3.7.0. This reflects an update to the page's revision-tracking UI/template, not a modification to the study data or history entries.
    Difference
    0.1%
    Check dated 2026-09-19T18:54:29.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page shows a revision bump from v3.6.5 to v3.6.6, indicating a backend or UI update; the study history content remains unchanged.
    Difference
    0.1%
    Check dated 2026-08-29T20:12:27.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new history entry on 2026-08-06 adds a 'Study Status' field and Revision: v3.6.5, while the 2026-05-01 entry and Revision: v3.6.4 were removed.
    Difference
    0.3%
    Check dated 2026-08-08T17:06:29.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a platform update reflected in the history record.
    Difference
    0.1%
    Check dated 2026-07-25T08:19:57.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page now shows a new site revision stamp (v3.6.3), replacing the previous v3.6.2, indicating a small platform update to the history view.
    Difference
    0.1%
    Check dated 2026-07-03T21:46:43.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2, reflecting a newer release of the site's record history viewer. This indicates an update to the page's underlying interface/version rather than study data.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:30.000Z thumbnail image

Stay in the know with updates to Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.